YG1699 / Youngene Therap  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
YG1699 / Youngene Therap
NCT04956263: A Comparison of Postprandial Glucose After a MMTT, and the Metabolic Effects of Insulin Withdrawal in a Crossover Study in Subjects With Type 1 Diabetes

Completed
2
19
US
YG1699, Dapagliflozin, Farxiga
Youngene Therapeutics Inc., Ltd., ProSciento
Diabetes, Diabetes Mellitus, Type 1, Type1diabetes, Diabetes Mellitus
02/22
07/22

Download Options